Will a warning label regarding potential suicide risks be added to Ozempic's labeling by June 30, 2024?
11
Ṁ190Ṁ1.1kresolved Jul 2
Resolved
NO1H
6H
1D
1W
1M
ALL
This market resolves to 'yes' if Ozempic's manufacturer or the FDA announces the inclusion of a warning label regarding potential suicide risks before or on June 30, 2024. Such an announcement must appear on official communication channels or major news publications. The market end date is June 30, 2024.
This question is managed and resolved by Manifold.
Market context
Get 
1,000 to start trading!
1,000🏅 Top traders
| # | Trader | Total profit |
|---|---|---|
| 1 | Ṁ149 | |
| 2 | Ṁ35 | |
| 3 | Ṁ23 | |
| 4 | Ṁ12 | |
| 5 | Ṁ5 |
People are also trading
Related questions
Ozempic will NOT be the leading GLP-1 agonist by total $ US sales by December 31, 2025
71% chance
Will there be a recall of Wegovy/Ozempic before 2035?
75% chance
Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
28% chance
Ozempic approval is revoked or withdrawn before 2031
6% chance
Will Steve austad regularly try ozempic by EOY 2028
31% chance
Will Matt Kaeberlein start taking semaglutide/ozempic by 2030?
41% chance
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
10% chance
How much will Ozempic cost in 2027 in the USA?
Nobel Prize awarded for Ozempic (or GLP-1 drugs) by 2030?
46% chance
will leopards need the ozempic after feasting on so many of the faces by 2029?
57% chance